Print

Merck & Co., Inc. (MRK) HIV Drug from Schering-Plough Corporation (SGP) Merger Fails Trials  
1/21/2010 7:15:33 AM

Bookmark and Share

Reuters -- Merck & Co on Wednesday said its experimental HIV treatment vicriviroc proved ineffective in two late-stage studies involving patients who had previously been treated with other HIV medicines.

//-->